WebTEPADINA is an alkylating drug indicated: To reduce the risk of graft rejection when used in conjunction with high-dose busulfan and cyclophosphamide as a preparative regimen for allogeneic hematopoietic progenitor (stem) cell transplantation (HSCT) for pediatric patients with class 3 beta-thalassemia. WebSep 17, 2024 · More information on Tepadina This product is no longer an orphan medicine. It was originally designated an orphan medicine on 29 January 2007. Tepadina was …
PRODUCT MONOGRAPH INCLUDING PATIENT …
WebMar 20, 2024 · The recommended dose of TEPADINA for treatment of superficial papillary carcinoma of the urinary bladder is 60 mg in 30 to 60 mL of Sodium Chloride Injection … Webthe breast or ovary is 0.3 to 0.4 mg/kg intravenously. (2.1) • The recommended dose of TEPADINA for treatment of malignant effusions is 0.6 to 0.8 mg/kg intracavitary . (2.1) • The recommended dose of TEPADINA for treatment of superficial papillary carcinoma of the urinary bladder is 60 mg in 30 to 60 mL of Sodium Chloride ff14 black coeurl minion
208264Orig1s000 - Food and Drug Administration
WebNov 1, 2024 · The recommended dose of Thiotepa for injection for treatment of adenocarcinoma of the breast or ovary is 0.3 to 0.4 mg/kg intravenously. Doses should be given at 1 to 4 week intervals. Initially the higher dose in … WebSep 21, 2024 · Tepadina side effects. Get emergency medical help if you have signs of an allergic reaction: hives; wheezing, difficult breathing; swelling of your face, lips, tongue, or throat.. Tepadina may cause serious side effects. Call your doctor at once if you have: sores or white patches in or around your mouth, trouble swallowing or talking, dry mouth, bad … WebThe recommended dose of TEPADINA for treatment of adenocarcinoma of the breast or ovary is 0.3 to 0.4 mg/kg intravenously. (2.1) The recommended dose of TEPADINA for … demographics in buda tx